A single Oxford Nanopore whole-genome sequencing workflow with adaptive sampling delivered results within hours while matching standard clinical assay coverage in pediatric cancer samples. Canadian researchers reported detection of fusion genes, small variants, copy number changes, and methylation classes in 36 pediatric cancer and control samples, accelerating turnaround without requiring separate workflows. If replicated in larger cohorts, adaptive sampling could reduce diagnostic lag for pediatric oncology where rapid molecular characterization influences trial matching and treatment planning. It also shifts attention toward sequencing pipelines as operational tools, not just data generation. Next steps include external validation, reproducibility across lab settings, and assessing how consistently the workflow performs across rare variant classes and sample quality constraints.